Oncopharmpod
Dacomitinib, cemiplimab & #oncopharm updates
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:27:47
- Mas informaciones
Informações:
Sinopsis
Dacomitinib & cemiplimab's respective FDA-approvals are discussed followed by a lightning-round review of 4 immunotherapy studies from the last week. We end with dosing updates for 2 multiple myeloma drugs.
